Half-year report · HY
286A.TEDINET S100YWR5
Period2026-01-01 → 2026-06-30
Filed2026-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥13.7bn | 2026-01-01 → 2026-06-30 | Cons. | Net sales |
| Revenue | ¥24.7bn | 2025-01-01 → 2025-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥10.5bn | 2025-01-01 → 2025-06-30 | Cons. | Net sales |
| Operating income | ¥395m | 2026-01-01 → 2026-06-30 | Cons. | Operating income |
| Operating income | ¥1.1bn | 2025-01-01 → 2025-06-30 | Cons. | Operating income |
| Ordinary income | ¥361m | 2026-01-01 → 2026-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.1bn | 2025-01-01 → 2025-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥981m | 2025-01-01 → 2025-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥256m | 2026-01-01 → 2026-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.2bn | 2025-01-01 → 2025-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥489m | 2026-01-01 → 2026-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.8bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥824m | 2025-01-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥560m | 2026-01-01 → 2026-06-30 | Cons. | Profit loss |
| Net income | ¥887m | 2025-01-01 → 2025-06-30 | Cons. | Profit loss |
| Total assets | ¥67.5bn | at 2026-06-30 | Cons. | Assets |
| Total assets | ¥65.1bn | at 2025-12-31 | Cons. | Assets |
| Total assets | ¥61.2bn | at 2025-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥45.2bn | at 2026-06-30 | Cons. | Liabilities |
| Total liabilities | ¥43.3bn | at 2025-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥22.3bn | at 2026-06-30 | Cons. | Net assets |
| Net assets / equity | ¥21.8bn | at 2025-12-31 | Cons. | Net assets |
| Net assets / equity | ¥19.7bn | at 2025-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥11.0bn | at 2026-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥9.1bn | at 2025-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥10.9bn | at 2026-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.1bn | at 2025-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.2bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥11.1bn | at 2024-12-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥551m | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥1.9bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥1.6bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | ¥92m | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.3bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.4bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥1.2bn | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.8bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥856m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥13.67 | 2026-01-01 → 2026-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥78.07 | 2025-01-01 → 2025-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.2 | 2025-01-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥13.57 | 2026-01-01 → 2026-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥76.75 | 2025-01-01 → 2025-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥22.75 | 2025-01-01 → 2025-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 31.2% | at 2026-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.5% | at 2025-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 30.3% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 50
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2026-01-01 → 2026-06-30 | ¥376m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2026-01-01 → 2026-06-30 | ¥376m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2026-01-01 → 2026-06-30 | ¥118m |
| Reconciling Itemsreconciling | revenue | 2026-01-01 → 2026-06-30 | −¥16m |
| Reconciling Itemsreconciling | revenue intersegment | 2026-01-01 → 2026-06-30 | −¥16m |
| Reconciling Itemsreconciling | segment profit | 2026-01-01 → 2026-06-30 | −¥731m |
| Comprehensive Medical Management Support Businessreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥5.1bn |
| Comprehensive Medical Management Support Businessreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥5.0bn |
| Comprehensive Medical Management Support Businessreportable segment | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥15m |
| Comprehensive Medical Management Support Businessreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥457m |
| Elderly Care Related Businessreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥4.4bn |
| Elderly Care Related Businessreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥4.4bn |
| Elderly Care Related Businessreportable segment | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥740,000 |
| Elderly Care Related Businessreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥312m |
| Specially Controlled Medical Device Businessreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥3.8bn |
| Specially Controlled Medical Device Businessreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥3.8bn |
| Specially Controlled Medical Device Businessreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥240m |
| —segment total | revenue | 2026-01-01 → 2026-06-30 | ¥13.3bn |
| —segment total | revenue external | 2026-01-01 → 2026-06-30 | ¥13.3bn |
| —segment total | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥16m |
| —segment total | segment profit | 2026-01-01 → 2026-06-30 | ¥1.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2026-01-01 → 2026-06-30 | ¥13.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2026-01-01 → 2026-06-30 | ¥13.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥16m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2026-01-01 → 2026-06-30 | ¥1.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-01-01 → 2025-06-30 | ¥219m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-01-01 → 2025-06-30 | ¥219m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-01-01 → 2025-06-30 | ¥41m |
| Reconciling Itemsreconciling | revenue | 2025-01-01 → 2025-06-30 | −¥640,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2025-01-01 → 2025-06-30 | −¥640,000 |
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-06-30 | −¥670m |
| Comprehensive Medical Management Support Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥3.1bn |
| Comprehensive Medical Management Support Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥3.1bn |
| Comprehensive Medical Management Support Businessreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥395,000 |
| Comprehensive Medical Management Support Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥1.3bn |
| Elderly Care Related Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥3.7bn |
| Elderly Care Related Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥3.7bn |
| Elderly Care Related Businessreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥245,000 |
| Elderly Care Related Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥187m |
| Specially Controlled Medical Device Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥3.6bn |
| Specially Controlled Medical Device Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥3.6bn |
| Specially Controlled Medical Device Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥276m |
| —segment total | revenue | 2025-01-01 → 2025-06-30 | ¥10.3bn |
| —segment total | revenue external | 2025-01-01 → 2025-06-30 | ¥10.3bn |
| —segment total | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥640,000 |
| —segment total | segment profit | 2025-01-01 → 2025-06-30 | ¥1.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-01-01 → 2025-06-30 | ¥10.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-01-01 → 2025-06-30 | ¥10.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥640,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-01-01 → 2025-06-30 | ¥1.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 552
| Item | Context | Value | Unit |
|---|---|---|---|
| Bonds payable | Prior1YearInstant | 20000000 | JPY |
| Bonds payable | InterimInstant | 20000000 | JPY |
| Long term loans payable | Prior1YearInstant | 16471859000 | JPY |
| Long term loans payable | InterimInstant | 16014045000 | JPY |
| Provision for repairs ncl | Prior1YearInstant | 51299000 | JPY |
| Provision for repairs ncl | InterimInstant | 63263000 | JPY |
| Lease obligations ncl | Prior1YearInstant | 6509028000 | JPY |
| Lease obligations ncl | InterimInstant | 6400688000 | JPY |
| Asset retirement obligations ncl | Prior1YearInstant | 756255000 | JPY |
| Asset retirement obligations ncl | InterimInstant | 759801000 | JPY |
| Guarantee deposits received2 ncl | Prior1YearInstant | 6932174000 | JPY |
| Guarantee deposits received2 ncl | InterimInstant | 6928799000 | JPY |
| Other ncl | Prior1YearInstant | 46232000 | JPY |
| Other ncl | InterimInstant | 73059000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 30786849000 | JPY |
| Noncurrent liabilities | InterimInstant | 30259657000 | JPY |
| Liabilities | Prior1YearInstant | 43346165000 | JPY |
| Liabilities | InterimInstant | 45150093000 | JPY |
| Capital stock | Prior1YearInstant | 100000000 | JPY |
| Capital stock | InterimInstant | 100000000 | JPY |
| Capital surplus | Prior1YearInstant | 8861044000 | JPY |
| Capital surplus | InterimInstant | 8897004000 | JPY |
| Retained earnings | Prior1YearInstant | 12019936000 | JPY |
| Retained earnings | InterimInstant | 12509195000 | JPY |
| Treasury stock | Prior1YearInstant | -509514000 | JPY |
| Treasury stock | InterimInstant | -510488000 | JPY |
| Shareholders equity | Prior1YearInstant | 20471467000 | JPY |
| Shareholders equity | InterimInstant | 20995712000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | -3009000 | JPY |
| Valuation difference on available for sale securities | InterimInstant | -3962000 | JPY |
| Deferred gains or losses on hedges | Prior1YearInstant | 64950000 | JPY |
| Deferred gains or losses on hedges | InterimInstant | 41773000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | -15760000 | JPY |
| Foreign currency translation adjustment | InterimInstant | -17178000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 46179000 | JPY |
| Valuation and translation adjustments | InterimInstant | 20633000 | JPY |
| Non controlling interests | Prior1YearInstant | 1261976000 | JPY |
| Non controlling interests | InterimInstant | 1299647000 | JPY |
| Net assets | Prior1YearInstant | 21779623000 | JPY |
| Net assets | InterimInstant | 22315992000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 65125788000 | JPY |
| Liabilities and net assets | InterimInstant | 67466086000 | JPY |
| Net sales | Prior1InterimDuration | 10520969000 | JPY |
| Net sales | InterimDuration | 13678443000 | JPY |
| Cost of sales | Prior1InterimDuration | 5769824000 | JPY |
| Cost of sales | InterimDuration | 8420818000 | JPY |
| Gross profit | Prior1InterimDuration | 4751144000 | JPY |
| Gross profit | InterimDuration | 5257624000 | JPY |
| Selling general and administrative expenses | Prior1InterimDuration | 3616427000 | JPY |
| Selling general and administrative expenses | InterimDuration | 4862491000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |